An interventional study of Hyaluronic Acid and Chondroitin Sulfate in Interstitial Cystitis, sponsored by Samsung Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2022-10-27.
Sponsored by Samsung Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Cystitis, Interstitial with a site in Korea, Republic of — 1 open to participants now, 1 under way, none of them phase 3. Cystitis, Interstitial · Korea, Republic of.
Among the 13 studies in Cystitis, Interstitial with a site in Korea, Republic of, this one is the only one that started in 2017, is one of 4 with no phase, and was the 9th registered.
236 studies on the registry are indexed under Cystitis, Interstitial; 35 are open to participants now.
Browse Cystitis, Interstitial studies →1 of the 13 studies in Cystitis, Interstitial with a site in Korea, Republic of is open now. Recruiting first, the newest first:
BLAD-HYA Group · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 25 Cystitis, Interstitial studies recruiting now, 15 (60%) set no upper age limit and 5 (20%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 62 is above the median of 51 across 158 interventional studies indexed under Cystitis, Interstitial.
Median enrollment 56 across the 6 interventional studies, 80 across the 7 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 13 have an industry lead sponsor. The 5 most frequent:
Samsung Medical Center is the lead sponsor of 1,011 studies on the registry; 152 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Samsung Medical Center has 5 studies filed under Cystitis, Interstitial — fewer than ten, so there is no comparison to draw.
1 of the studies in Cystitis, Interstitial with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07495072BLAD-HYA GroupEarly vs Delayed Intravesical Blad-Care During BCG Therapy | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Cystitis, Interstitial with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate after transurethral resection of Hunner lesion in interstitial cystitis/bladder pain syndrome patients. To analyze the number and timing of recurrence based on a long-term follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intravesical instillation of Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients.
Drug: Hyaluronic Acid and Chondroitin Sulfate
Drug pages: Hyaluronic Acid · Chondroitin Sulfates
Intravesical instillation of Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients.
change in recurrence rate in Hyaluronic Acid and Chondroitin Sulfate instillation group after transurethral resection treatment
Time frame: Every 3 months for 2 years
changes in mean number of daytime frequency episodes
Time frame: Every 3 months for 2 years
changes in mean number of nocturia episodes
Time frame: Every 3 months for 2 years
changes in mean number of urgency episodes
Time frame: Every 3 months for 2 years
Change score of O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q)
Time frame: Every 3 months for 2 years
Change score of Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF)
Time frame: Every 3 months for 2 years
Score of Global Response Assessment (GRA)
Time frame: Every 3 months for 2 years
Patient Global Assessment
Time frame: at the end of the treatment(2 years)
Occurrence of adverse event
Time frame: Every 3 months for 2 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2017 to primary completion in Sep 2019, 24 months.
Of 35 non-industry interventional studies with no phase under Cystitis, Interstitial, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 34. This study's 24 months is close to that.
Counting every sponsor, half of 39 studies reached it within 23 months; a quarter within 16 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Hyaluronic Acid · Chondroitin Sulfates